Issue: May 25, 2016
May 25, 2016
1 min read
Save

Prostate Cancer Drugs in the Pipeline

Issue: May 25, 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

HemOnc Today presents this guide to drugs in phase 2 or phase 3 development for prostate cancer. Clinicians can use this chart as a quick reference to learn about the status of those drugs that may be clinically significant to their practice.

Prostate Cancer Drugs in the Pipeline
Information in this chart was compiled from the Pharmaceutical Research and Manufacturers of America, NIH (www.clinicaltrials.gov), corporate websites and the databases of HemOnc Today. The publisher or editors do not assume responsibility for any errors or omissions.